Skip to main content
Screener/Healthcare/Biotechnology

ABCL — AbCellera Biologics Inc.

NASDAQ
$11.43+0.03 (+0.22%)
Mid CapUnder $20HealthcareFastest Growing
$2.75
$12.58
$11.18
$11.73
EPS (TTM)$-0.48
P/E Ratio-8.50
Dividend Yield—
Market Cap$3.49B
Volume2.35M
Prev Close$11.41
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$8.3M-$43.2M$-0.140.0%-519.1%
Q4 '25$44.9M-$8.9M$-0.03100.0%-19.9%
Q3 '25$9.0M-$57.1M$-0.19100.0%-637.8%
Q2 '25$17.1M-$34.7M$-0.12100.0%-203.3%
Q1 '25$4.2M-$45.6M$-0.15100.0%-1077.2%
Q4 '24$5.0M-$34.2M$-0.12100.0%-677.4%
Q3 '24$6.5M-$51.1M$-0.17100.0%-785.4%
Q2 '24$7.3M-$36.9M$-0.13100.0%-504.3%
Get Your Daily Market Recap
ABCL Stock Price, Chart & Analysis